These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 31319859

  • 1. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
    Vázquez-Ríos AJ, Molina-Crespo Á, Bouzo BL, López-López R, Moreno-Bueno G, de la Fuente M.
    J Nanobiotechnology; 2019 Jul 18; 17(1):85. PubMed ID: 31319859
    [Abstract] [Full Text] [Related]

  • 2. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC, Kim OY, Yoon CM, Choi DS, Roh TY, Park J, Nilsson J, Lötvall J, Kim YK, Gho YS.
    ACS Nano; 2013 Sep 24; 7(9):7698-710. PubMed ID: 24004438
    [Abstract] [Full Text] [Related]

  • 3. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S, Nguyen TDT, Marasini R, Aryal S.
    Acta Biomater; 2019 Aug 24; 94():482-494. PubMed ID: 31129363
    [Abstract] [Full Text] [Related]

  • 4. Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity.
    Wang L, Zhou X, Zou W, Wu Y, Zhao J, Chen X, Zhou GG.
    J Nanobiotechnology; 2020 Oct 27; 18(1):153. PubMed ID: 33109196
    [Abstract] [Full Text] [Related]

  • 5. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M, Zhao X, Xing H, Liu H, Lang L, Yang T, Xun Z, Wang D, Ding P.
    Acta Biomater; 2019 Sep 15; 96():517-536. PubMed ID: 31284098
    [Abstract] [Full Text] [Related]

  • 6. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
    Zhan Q, Yi K, Qi H, Li S, Li X, Wang Q, Wang Y, Liu C, Qiu M, Yuan X, Zhao J, Hou X, Kang C.
    Theranostics; 2020 Sep 15; 10(17):7889-7905. PubMed ID: 32685027
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H, Kim EH, Kwak G, Chi SG, Kim SH, Yang Y.
    Int J Mol Sci; 2020 Dec 22; 22(1):. PubMed ID: 33374978
    [Abstract] [Full Text] [Related]

  • 9. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D.
    Acta Pharmacol Sin; 2017 Jun 22; 38(6):754-763. PubMed ID: 28392567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N, Corbo C, Evangelopoulos M, Pastò A, Zuco V, Tasciotti E.
    Curr Med Chem; 2019 Jun 22; 26(33):6132-6148. PubMed ID: 30182846
    [Abstract] [Full Text] [Related]

  • 12. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations.
    Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, Kabanov AV, Batrakova EV.
    Nanomedicine; 2018 Jan 22; 14(1):195-204. PubMed ID: 28982587
    [Abstract] [Full Text] [Related]

  • 13. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X, Hu M, Wang Z, Zhang W, Li J, Yang H, Lin J, Xing B.
    Bioconjug Chem; 2018 Apr 18; 29(4):838-851. PubMed ID: 29509403
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
    Wu JY, Li YJ, Wang J, Hu XB, Huang S, Luo S, Xiang DX.
    J Nanobiotechnology; 2021 Dec 06; 19(1):405. PubMed ID: 34872569
    [Abstract] [Full Text] [Related]

  • 16. Targeted exosome-based nanoplatform for new-generation therapeutic strategies.
    Yin W, Ma H, Qu Y, Wang S, Zhao R, Yang Y, Guo ZN.
    Biomed Mater; 2024 Mar 25; 19(3):. PubMed ID: 38471163
    [Abstract] [Full Text] [Related]

  • 17. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW, Nguyen J.
    J Control Release; 2016 Apr 28; 228():179-190. PubMed ID: 26941033
    [Abstract] [Full Text] [Related]

  • 18. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
    Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, Cores J, Dinh PU, Allen T, Shen D, Liang H, Li Y, Cheng K.
    Theranostics; 2020 Apr 28; 10(8):3474-3487. PubMed ID: 32206102
    [Abstract] [Full Text] [Related]

  • 19. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
    Parodi A, Molinaro R, Sushnitha M, Evangelopoulos M, Martinez JO, Arrighetti N, Corbo C, Tasciotti E.
    Biomaterials; 2017 Dec 28; 147():155-168. PubMed ID: 28946131
    [Abstract] [Full Text] [Related]

  • 20. Towards analyzing the potential of exosomes to deliver microRNA therapeutics.
    Giassafaki LN, Siqueira S, Panteris E, Psatha K, Chatzopoulou F, Aivaliotis M, Tzimagiorgis G, Müllertz A, Fatouros DG, Vizirianakis IS.
    J Cell Physiol; 2021 Feb 28; 236(2):1529-1544. PubMed ID: 32749687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.